(1S,4aS,5R,7S,7aS)-1-(beta-D-Glucopyranosyloxy)-4a,5-dihydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-7-yl acetate(CAS: 6926-14-3)

The compound (1S,4aS,5R,7S,7aS)-1-(beta-D-Glucopyranosyloxy)-4a,5-dihydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-7-yl acetate (CAS: 6926-14-3) is subject to the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), European Chemicals Agency (ECHA) REACH regulations, and requirements by the U.S. Food and Drug Administration (FDA) and Environmental Protection Agency (EPA). Specific hazard categories, such as flammability and toxicity, must be determined for precise regulatory compliance.

In synthesis, alternatives to (1S,4aS,5R,7S,7aS)-1-(beta-D-Glucopyranosyloxy)-4a,5-dihydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-7-yl acetate (CAS: 6926-14-3) include using other types of sugar derivatives or simpler acetates. Commonly used alternatives include glucose acetate or fructose acetate, which can serve as starting materials for similar chemical transformations.

The market for (1S,4aS,5R,7S,7aS)-1-(beta-D-Glucopyranosyloxy)-4a,5-dihydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-7-yl acetate (CAS: 6926-14-3) is growing due to its use in pharmaceuticals and natural product synthesis. Research trends focus on its application in antiviral and antimicrobial compounds, as well as in the development of new therapeutic agents.

Waste containing (1S,4aS,5R,7S,7aS)-1-(beta-D-Glucopyranosyloxy)-4a,5-dihydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-7-yl acetate (CAS: 6926-14-3) should be collected and treated as hazardous waste. Proper disposal methods include incineration or professional waste disposal services that comply with local regulations. Environmental protection measures such as minimizing secondary contamination and ensuring worker safety must be strictly followed during handling and disposal to prevent environmental damage.